“The difficult period that goes on to install new supply channels, a labeling system, the timeliness of input, and so on, adaptation, has passed,” TASS quoted Murashko as saying at the St. Petersburg International Economic Forum (SPIEF).
Earlier, First Deputy Minister of Health Viktor Fisenko said that Russia is capable of producing about 80% of the entire range from the list of vital drugs.
According to Rosstat, in April 2022, drug production volumes increased by 35.9% compared to the same period last year.